90/019,490Occlusion Device10,130,372Closed

Status

Reexamination Certificate Issued

Filed

Apr 18, 2024

Last Updated

Oct 24, 2025

Art Unit

3993

Requester

Unknown

Requester Law Firm

Unknown

Requested By

Third Party

P.O. Law Firm

MbHb

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61BDiagnosis & Surgery

USPC

606Surgery

Reexam History (30 events)

Oct 24, 2025REEXInput Issue Number and Issue Date for Reexamination
Oct 5, 2025RXPUBSReexam Forwarded to Office of Publications
Sep 3, 2025MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Aug 27, 2025RXLITSRReexam Litigation Search Conducted
Jul 18, 2025RXC/SRCertificate of Service
Jul 18, 2025RXA...Response after Non-Final Action
May 22, 2025MREPQRX - Mail Ex Parte Quayle Action
Apr 21, 2025RXC/SRCertificate of Service
Apr 21, 2025RXA...Response after Non-Final Action
Feb 20, 2025MR.NFRX - Mail Reexam Non-Final Action
Dec 30, 2024RXA...Response after Non-Final Action
Oct 30, 2024MR.NFRX - Mail Reexam Non-Final Action
Jul 24, 2024RXFWDXDate Forwarded to Examiner
May 13, 2024MREXORX - Mail Ex Parte Request for Reexamination Granted
May 3, 2024RXLITSRReexam Litigation Search Conducted
Apr 25, 2024MRXNReexamination Formalities Notice Mailed
Apr 25, 2024MRXNReexamination Formalities Notice Mailed
Apr 25, 2024DOCKCase Docketed to Examiner in GAU
Apr 24, 2024RXTTLRPTTitle Report
Apr 24, 2024RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Apr 24, 2024RXNREQFDNotice of reexamination request filing date
Apr 24, 2024RXNREQAUNotice of assignment of reexamination request
Apr 24, 2024FTFSFITF set to YES - revise initial setting
Apr 23, 2024FTFSFITF set to YES - revise initial setting
Apr 18, 2024RXOSUB.RReexamination requested by third party requester
Apr 18, 2024RXOSUBReceipt of Original Ex Parte Reexam Request
Apr 18, 2024RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Apr 18, 2024RXC/SRCertificate of Service
Apr 18, 2024RXAF/DRReexam - Affidavit(s), Declaration(s) and/or Exhibit(s) Filed by Third Party Requester
Apr 18, 2024BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Nov 20, 2018
3.5-yr
May 20, 2022
Paid May 20, 2022
7.5-yr
May 20, 2026
11.5-yr
May 20, 2030
Expiry
Apr 29, 2035

Entity Status

Large Entity

Expires

Apr 29, 2035 (9.1 yr remaining)

Assignments

201620172018201920202021202220232024FiledSTEPHEN GRIFFINCERUS ENDOVASCULAR LIMITEDSTRYKER IRELAND TECHNOLOGY LTD.CERUS ENDOVASCULAR LIMITEDSecurity InterestMIDCAP FINANCIAL TRUSTRelease
AssignmentReel/Frame: 035548/0033Recorded: Apr 29, 2015

From

STEPHEN GRIFFINInventor
Apr 21, 2015

To

CERUS ENDOVASCULAR LIMITED

Security InterestReel/Frame: 062665/0626Recorded: Feb 11, 2023

From

CERUS ENDOVASCULAR LIMITED
Feb 3, 2023
CERUS ENDOVASCULAR, INC.
Feb 3, 2023

To

MIDCAP FINANCIAL TRUST

ReleaseReel/Frame: 063515/0943Recorded: May 2, 2023

From

MIDCAP FINANCIAL TRUST
May 2, 2023

To

CERUS ENDOVASCULAR, INC.

AssignmentReel/Frame: 066667/0328Recorded: Mar 6, 2024

From

CERUS ENDOVASCULAR LTD.
Feb 22, 2024

To

STRYKER IRELAND TECHNOLOGY LTD.